Linc AB (STO:LINC)

Market Cap	4.00B -5.4%
Revenue (ttm)	71.86M
Net Income	72.54M
EPS	1.25
Shares Out	57.60M
PE Ratio	55.36
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,709
Open	69.50
Previous Close	69.70
Day's Range	68.70 - 69.80
52-Week Range	58.90 - 78.10
Beta	0.74
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC

Financial Performance

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Nov 3, 2026

Data Sources Report a data error